FIM
ORGS

Freedom Investment Management’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Freedom Investment Management’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,253
Closed -$17.4K – 769
2023
Q2 		$17.4K Buy
+1,253
New +$14.8K ﹤0.01% 695

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Freedom Investment Management's ORGS Position: Q3 2023 in Review

Freedom Investment Management sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2023, closing a stake of 1,253 shares — an estimated $17.4K sold.

Freedom Investment Management first reported a position in ORGS in Q2 2023 and held it in 1 quarter. The position peaked at $17.4K in Q2 2023. 20 funds tracked by Wall St. Rank hold ORGS as of Q3 2023.

  • Freedom Investment Management reported no remaining Orgenesis Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Freedom Investment Management sold 1,253 Orgenesis Inc. Common Stock shares in Q3 2023, an estimated $17.4K.
  • Freedom Investment Management first reported a position in Orgenesis Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Freedom Investment Management's Orgenesis Inc. Common Stock position peaked at $17.4K in Q2 2023.
  • 20 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2023.

Based on Freedom Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.